At present, the reality is that vaccines are scarce. If vaccines can be vaccinated in different places, we should pay attention to vaccination at regular vaccination sites. The vaccines at regular inoculation points in China are distributed by the district CDC, and each one can be traced back to where it was sent and to whom it was inoculated.
Nine-valent HPV vaccine is used to prevent cervical cancer caused by human papillomavirus (HPV) infection, which can prevent more than 90% of cervical cancer. Vaccines usually need to be injected three times, ***6 months, to take effect.
Vaccination is primary prevention and screening is secondary prevention, both of which are equally important. Cervical cancer screening measures should not be relaxed because of vaccination.
Nine-valent HPV vaccine has good immunogenicity. After three doses of inoculation, the positive conversion rate of serum antibodies of related types can almost reach 100%. After vaccination 1 month, the peak geometric average titer of antibody can reach 100 times of the antibody level after natural infection, and this value will drop to 10 times in the next two months, and will remain in the platform period. The antibody level of the vaccine can be maintained for at least 4 years.
Clinical trials show that vaccination with nine-valent HPV vaccine can produce good protective effect, effectively reduce the persistent infection of corresponding types of human papillomavirus and precancerous lesions of cervix, vagina and external genitalia, and the protective effect can reach more than 90%. Nine-valent HPV vaccine contains human papillomavirus -6 and human papillomavirus-1 1 VLP, which has a good preventive effect on condyloma acuminatum.
The State Administration of Pharmaceutical Products has the conditions to approve the marketing of the nine-valent human papillomavirus vaccine (HPV vaccine) for preventing cervical cancer. The State Administration of Pharmaceutical Products requires enterprises to formulate risk control plans and conduct post-marketing research as required.
laws and regulations
People's Republic of China (PRC) Basic Medical Care and Health Promotion Law
Article 3 Medical and health undertakings shall adhere to the people-oriented principle and serve people's health. Medical and health undertakings should adhere to the principle of public welfare. Article 4 The state and society respect and protect citizens' right to health. The state implements the strategy of healthy China, popularizes healthy life, optimizes health services, improves health protection, builds a healthy environment, develops health industries, and improves the health level of citizens throughout their life cycle. The state establishes a health education system to protect citizens' right to health education and improve citizens' health literacy.
People's Republic of China (PRC) Basic Medical Care and Health Promotion Law
Article 5 Citizens have the right to obtain basic medical and health services provided by the state and society according to law.